Category: Candy, confectionary, snacks and sweeteners
What to do: Do not consume recalled products to which you are allergic or sensitive.
Audience: General public
Recall class: Class 1
Affected products
Brand
Product
Size
UPC
Codes
Crave Stevia
Almond All Natural Chocolate
80 g
85 g
8 84063 00088 3
All codes where milk is not declared on the label
Crave Stevia
Dark All Natural Chocolate
80 g
85 g
8 84063 00085 2
All codes where milk is not declared on the label
Crave Stevia
Mint All Natural Chocolate
80 g
85 g
8 84063 00084 5
All codes where milk is not declared on the label
Crave Stevia
Sea Salt All Natural Chocolate
80 g
85 g
8 84063 00083 8
All codes where milk is not declared on the label
Crave Stevia
Sprinkles All Natural Chocolate
80 g
85 g
8 84063 00118 7
All codes where milk is not declared on the label
Crave Stevia
Chocolate Chips
200 g
8 84063 00069 2
All codes where milk is not declared on the label
Issue
The affected products are being recalled from the marketplace because they may contain milk which is not declared on the label.
The recalled products have been sold in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, and Nova Scotia, and may have been distributed in other provinces and territories. They have also been sold online.
What you should do
Check to see if you have recalled products
Do not consume recalled products to which you are allergic or sensitive as they may cause a serious or life-threatening reaction
Do not serve, use, sell or distribute recalled products
Recalled products should be thrown out or returned to the location where they were purchased
The Children's Tumor Foundation (CTF) announces nearly 400 world-famous buildings, bridges, waterfalls, castles and architectural icons are participating in this year's Shine a Light on NF campaign and will show their support in the global fight...
Guardant Health, Inc. , a leading precision oncology company, today announced that on April 22, 2024, the Compensation Committee of Guardant's Board of Directors approved the granting of restricted stock units ("RSUs") representing 215,601 shares of...
Victoria Eye Center/Victoria Surgery Center/Victoria Vision Center ("VEC") is writing to provide information regarding an event that involves certain information relating to personal health information. On March 21, 2024, VEC became aware that...
Azitra, Inc. , a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced preclinical data from the Company's platform and pipeline. The data are being presented on Friday, May 17,...
Immunome, Inc. , a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the promotion of Max Rosett to Chief Financial Officer, effective May 9. Mr. Rosett most recently held the role...
Arcadia Biosciences, Inc.® , a producer and marketer of innovative, plant-based health and wellness products, today announced that it will host a call for analysts and investors after market close on May 22, 2024.
The company has scheduled a...